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The importance of fungal organisms as allergens and pathogens has
been increasing considerably over the last decade. This is due, on the
one hand, to a general increase in the incidence of allergies, but also to
the growing number of immunocompromised individuals such as AIDS
patients or transplant recipients.
This book summarizes what is currently known about the allergens
of Candida, Aspergillus, Cladosporium, Alternaria, Coprinus, and
Psilocybe, among others, and describes the application of recombinant
allergens for diagnosis and new forms of therapy. The virulence factors
and defense mechanisms against Aspergillus and Candida infections are
discussed as are the various causes of superficial skin infections with
fungi and the aerobiology of fungal spores and mycelia. A comprehensive
chapter on fungal toxins and their importance for human and animal
health is included, followed by a summary of the present state of fungal
genome sequencing. Finally, the now generally accepted new sequence-
based systematics and phylogeny of allergenic and pathogenic fungi is
presented. A glossary explains the highly specialized terminology of
clinical and systematic mycology for the nonspecialist.
Summarizing the most up-to-date molecular and clinical findings,
this publication will be of interest not only to allergologists, mycologists
and biologists, but to all clinicians who want to learn more about clinically
important fungi as well as to lawyers concerned with lawsuits on “sick
building syndrome”.
The book Series Chemical Immunology: Appearing for the first
time in 1939, “Progress in Allergy” was the first and for many years, the
only international review series in the English language devoted to
Immunology. The present title, “Chemical Immunology”, reflects the
rapidly increasing role of concepts and techniques of molecular and cell
biology, as well as the greater emphasis now being placed on research
into the biologic problems of immunology, hypersensitivity and
immunopathology. Highly specialized, single-topic volumes keep both
investigators and practicing physicians up to date with the latest
developments in areas of immunology where recent research has been
concentrated.
S. Karger AG
P.O. Box
CH-4009 Basel – Switzerland
E-mail: karger@karger.ch
Fax: +41 61 306 12 34
www.karger.com/chemi
